2021
DOI: 10.1007/s10565-021-09595-z
|View full text |Cite
|
Sign up to set email alerts
|

The HNF1A-AS1/miR-92a-3p axis affects the radiosensitivity of non-small cell lung cancer by competitively regulating the JNK pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 32 publications
0
16
0
Order By: Relevance
“…Several studies have described the functions of miR-92a-3p in a variety of human malignancies, including CC (Mao et al, 2020;Jinghua et al, 2021;Wang et al, 2021). For example, miR-92a-3p regulated breast cancer cell proliferation and metastasis via regulating B-cell translocation gene 2 (BTG2) (Jinghua et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Several studies have described the functions of miR-92a-3p in a variety of human malignancies, including CC (Mao et al, 2020;Jinghua et al, 2021;Wang et al, 2021). For example, miR-92a-3p regulated breast cancer cell proliferation and metastasis via regulating B-cell translocation gene 2 (BTG2) (Jinghua et al, 2021).…”
Section: Discussionmentioning
confidence: 99%
“…Previously, cancer-related studies have shown that miR-92a can suppress cell proliferation and induce apoptosis [ 35 , 36 ]. Consistent with these findings, upregulation of miR-92a-2-5p could inhibit proliferation and enhance apoptosis of intestinal cells, indicating that miR-92a-2-5p may play an important role in the cell cycle, as well as in growth and differentiation [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…LncRNA has been proved to regulate various biological processes such as cell proliferation, apoptosis, invasion and metastasis, which provides a new perspective for our diagnosis and treatment of cancer (25). HNF1A-AS1 is highly expressed in diverse tumors, promoting the proliferation of triplenegative breast cancer (26), hepatocellular carcinoma (27) and glioma (28); proliferation, migration and invasion of osteosarcoma (29); proliferation, apoptosis, chemoresistance of non-small-cell cancer (NSCLC) (30); proliferation, migration, EMT of oral squamous cell carcinoma (31); invasion, metastasis, angiogenesis and lymphangiogenesis of gastric cancer (32); metastasis and invasion of bladder cancer (33); proliferation, migration and invasion of oesophageal adenocarcinoma (34). Our results from TCGA database and clinical samples showed that HNF1A-AS1 was highly expressed in CRC.…”
Section: Discussionmentioning
confidence: 99%